SYDNEY, AUSTRALIA – 6 September 2023 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces its management will participate in the following upcoming investor conferences in September:
-- The 18th Annual Citi Biopharma Conference in Boston, MA on Thursday, September 7.
-- Bell Potter Emerging Ideas Leaders Conference on September 12. Presentation at 3:30 p.m. AEST.
-- Baird’s 2023 Global Healthcare Conference in New York City, NY on September 12. Fireside chat at 3:45 p.m. ET.
-- E&P Small Cap Healthcare Conference in Sydney, NSW. Presentation on September 13 at 4:25 p.m. AEST.
-- 2023 Cantor Global Healthcare Conference in New York City, NY on September 26. Panel presentation at 2:45 p.m. ET.
For more information, download the attached PDF.
Download this document
